Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05680675 · ClinicalTrials.gov registry record · NA
Dual-Tracer Theranostic PET
A NA study of Prostate Cancer and Neuroendocrine Tumors, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT05680675: Completed NA study of Prostate Cancer and Neuroendocrine Tumors, sponsored by University of Utah.
NCT05680675 is a NA study of Prostate Cancer and Neuroendocrine Tumors that has completed, run by University of Utah. The registered enrollment target is 50 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05680675, a NA study of Prostate Cancer and Neuroendocrine Tumors, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is designed to obtain positron emission tomography with x-ray computed tomography (PET/CT) imaging data with each tracer pair, providing the imaging data needed to develop new simultaneous dual-tracer imaging techniques and processing algorithms for these tracer pairs.
Primary Outcome
To obtain PET/CT imaging data suitable for developing new simultaneous dual-tracer PET techniques and processing algorithms for dual-tracer imaging of Fluorine-18 fluorodeoxyglucose (FDG) + Cu64-dodecane tetraacetic acid (DOTA) tyrosine-3-octreotate (TATE) (DOTATATE), FDG + Ga68-DOTATATE, and FDG + Ga68-prostate-specific membrane antigen (PSMA)-11 PET/CT
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Single-Tracer FDG PET/CT Exam
- DIAGNOSTIC_TEST Single-Tracer Cu64-DOTATATE PET/CT Exam
- DIAGNOSTIC_TEST Single-Tracer Ga68-DOTATATE PET/CT Exam
- DIAGNOSTIC_TEST Single-Tracer PSMA PET/CT Exam
Study Locations (1)
Utah
- Huntsman Cancer Institute - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-12-08 |
| Est. Completion | 2024-06-04 |
| Phase | NA |
What the finished NCT05680675 record still lists
NCT05680675 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Prostate Cancer appearing as the primary indexed condition, and to 4 interventions - of which Single-Tracer FDG PET/CT Exam is the first listed.
NCT05680675 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT05680675 about?
NCT05680675 is a clinical study titled "Dual-Tracer Theranostic PET". This study is designed to obtain positron emission tomography with x-ray computed tomography (PET/CT) imaging data with each tracer pair, providing the imaging data needed to develop new simultaneous dual-tracer imaging techniques and processing algorithms for these tracer pairs.
What is the current status of trial NCT05680675?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2022-12-08. Estimated completion is 2024-06-04.
What conditions does trial NCT05680675 study?
This clinical trial studies the following conditions: Prostate Cancer, Neuroendocrine Tumors.
What interventions are being tested in trial NCT05680675?
The interventions under investigation include: Single-Tracer FDG PET/CT Exam (DIAGNOSTIC_TEST), Single-Tracer Cu64-DOTATATE PET/CT Exam (DIAGNOSTIC_TEST), Single-Tracer Ga68-DOTATATE PET/CT Exam (DIAGNOSTIC_TEST), Single-Tracer PSMA PET/CT Exam (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05680675?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05680675 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05680675's enrollment target sits among peer trials
50 469th of 735 higher than 247 of 735 other Prostate Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
RECRUITING · NA
-
Diffusion Basis Spectrum Imaging of the Prostate
RECRUITING · NA
-
Micro-UltraSound In Cancer - Active Surveillance
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
SBRT Boost for Unfavorable Prostate Cancer'
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI